<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0016155"><a href="http://purl.obolibrary.org/obo/MONDO_0016155">MONDO:0016155</a></h3>
<p><strong>Label:</strong> qualitative or quantitative defects of protein involved in O-glycosylation of alpha-dystroglycan</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019523">MONDO:0019523</a> (Walker-Warburg syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0016157">MONDO:0016157</a> (qualitative or quantitative defects of fukutin), <a href="http://purl.obolibrary.org/obo/MONDO_0014683">MONDO:0014683</a> (muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 9), <a href="http://purl.obolibrary.org/obo/MONDO_0016156">MONDO:0016156</a> (qualitative or quantitative defects of FKRP), <a href="http://purl.obolibrary.org/obo/MONDO_0016184">MONDO:0016184</a> (qualitative or quantitative defects of protein O-mannosyltransferase 1), <a href="http://purl.obolibrary.org/obo/MONDO_0016185">MONDO:0016185</a> (qualitative or quantitative defects of protein O-mannosyltransferase 2), <a href="http://purl.obolibrary.org/obo/MONDO_0016182">MONDO:0016182</a> (qualitative or quantitative defects of protein O-mannose beta1,2N-acetylglucosaminyltransferase),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_207122">Orphanet:207122</a>, <a href="http://www.orpha.net/ORDO/Orphanet_209033">Orphanet:209033</a>, <a href="http://purl.obolibrary.org/obo/OMIM_253800">OMIM:253800</a>, <a href="http://www.orpha.net/ORDO/Orphanet_209024">Orphanet:209024</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615041">OMIM:615041</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615181">OMIM:615181</a>, <a href="http://www.orpha.net/ORDO/Orphanet_209030">Orphanet:209030</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615287">OMIM:615287</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613150">OMIM:613150</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613153">OMIM:613153</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613154">OMIM:613154</a>, <a href="http://purl.obolibrary.org/obo/OMIM_253280">OMIM:253280</a>, <a href="http://purl.obolibrary.org/obo/OMIM_616538">OMIM:616538</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614830">OMIM:614830</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614643">OMIM:614643</a>, <a href="http://purl.obolibrary.org/obo/OMIM_615249">OMIM:615249</a>, <a href="http://www.orpha.net/ORDO/Orphanet_207119">Orphanet:207119</a>, <a href="http://www.orpha.net/ORDO/Orphanet_899">Orphanet:899</a>, <a href="http://www.orpha.net/ORDO/Orphanet_370997">Orphanet:370997</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0011021">HP:0011021</a> (Abnormality of circulating enzyme level) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0010876">HP:0010876</a> (Abnormality of circulating protein level) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003236">HP:0003236</a> (Elevated serum creatine phosphokinase) and <a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) and <a href="http://purl.obolibrary.org/obo/HP_0100547">HP:0100547</a> (Abnormality of forebrain morphology) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0030724">HP:0030724</a> (Central nervous system cyst) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0012759">HP:0012759</a> (Neurodevelopmental abnormality) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0012639">HP:0012639</a> (Abnormality of nervous system morphology) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0012638">HP:0012638</a> (Abnormality of nervous system physiology) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0012443">HP:0012443</a> (Abnormality of brain morphology) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0012374">HP:0012374</a> (Abnormality of the globe) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0012372">HP:0012372</a> (Abnormal eye morphology) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0011805">HP:0011805</a> (Abnormality of muscle morphology) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0011283">HP:0011283</a> (Abnormality of the metencephalon) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0006829">HP:0006829</a> (Severe muscular hypotonia) and <a href="http://purl.obolibrary.org/obo/HP_0011282">HP:0011282</a> (Abnormality of hindbrain morphology) and <a href="http://purl.obolibrary.org/obo/HP_0040081">HP:0040081</a> (Abnormal levels of creatine kinase in blood) 62.08%</li>
</ul>
</body>
</html>
